Variopartner SICAV - MIV Global Medtech Fund P1

Reference Data

ISIN LU0329630999
Valor Number 3535010
Bloomberg Global ID VARMVP1 LX
Fund Name Variopartner SICAV - MIV Global Medtech Fund P1
Fund Provider MIV Global Medtech Fund Feldeggstrasse 55
8008 Zürich
Schweiz
Phone: +41 44 253 64 11
E-Mail: info@mivam.ch
Fund Provider MIV Global Medtech Fund
Representative in Switzerland Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Distributor(s) Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology.
Peculiarities

Fund Prices

Current Price * 2,466.21 CHF 19.11.2024
Previous Price * 2,481.82 CHF 18.11.2024
52 Week High * 2,503.20 CHF 27.03.2024
52 Week Low * 2,060.33 CHF 28.11.2023
NAV * 2,466.21 CHF 19.11.2024
Issue Price * 2,466.21 CHF 19.11.2024
Redemption Price * 2,466.21 CHF 19.11.2024
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,904,354,230
Unit/Share Assets *** 243,243,323
Trading Information SIX

Performance

YTD Performance +15.62% 29.12.2023
19.11.2024
1 month +0.74% 21.10.2024
19.11.2024
3 months +4.54% 19.08.2024
19.11.2024
6 months +1.03% 21.05.2024
19.11.2024
1 year +20.11% 20.11.2023
19.11.2024
2 years +13.79% 21.11.2022
19.11.2024
3 years -15.06% 19.11.2021
19.11.2024
5 years +10.42% 19.11.2019
19.11.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 0.1183
ADDI Date 19.11.2024

Top 10 Holdings ***

Abbott Laboratories 9.94%
Boston Scientific Corp 9.92%
Intuitive Surgical Inc 9.91%
Stryker Corp 9.80%
Medtronic PLC 4.96%
Alcon Inc 4.37%
Essilorluxottica 4.24%
Becton Dickinson & Co 4.11%
Hoya Corp 3.95%
Edwards Lifesciences Corp 3.67%
Last data update 31.10.2024

Cost / Risk

TER 1.57%
TER date 28.06.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.56%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)